Coca-Cola Is Outperforming Broadcom and Every "Magnificent Seven" Stock in 2026. Is It Still a Top Dividend Stock to Buy in September?

Coca-Cola shares have gained about 26% year-to-date, outpacing the S&P 500's 13.6% return and all Magnificent Seven stocks, supported by Q2 2026 net revenue growth of 7% and adjusted EPS growth of 16%. Management expects full-year EPS growth of 9%-10%, aided by World Cup-related brand volume gains and U.S.-dollar currency tailwinds. However, the stock now trades near 25x forward earnings versus a historical low-20s multiple, creating downside risk if temporary sponsorship and FX benefits fade; the article suggests waiting for a pullback toward a 3%+ forward dividend yield versus the current 2.4%.

Analysis

KO’s rerating leaves little room for a return to its normal execution profile. A move from roughly 25x forward EPS back toward a 21-22x range implies 12-16% downside before considering any earnings revision; the dividend cushions carry but does not offset a multiple-led correction. The key issue is that event-led demand and FX translation are low-quality sources of earnings durability relative to sustained pricing, mix, and unit-case growth.

Near term (days to weeks), KO can remain supported by defensive-factor flows if AI capex concerns persist and real yields decline. Over the next 1-3 months, the relevant catalyst is whether management can retain elevated organic growth and operating leverage after promotional/event spending normalizes; a stronger dollar would compound the risk by converting an operational deceleration into an EPS miss. The 6-18 month risk is that investors reclassify KO from a growth-staples beneficiary back to a bond-proxy staple, making the equity more sensitive to Treasury yields and its historical valuation band.

PEP is not automatically the clean long leg despite its substantial valuation discount: its discount reflects real execution and margin issues. The better relative expression is to fade KO-specific multiple expansion while retaining broad staples exposure, rather than assume convergence to PEP. Contrarian upside would require evidence that KO’s higher volume growth is persisting outside event-linked channels and that FX remains supportive; absent that, consensus may still be underestimating the speed of a de-rating in a crowded defensive winner.

Key Decisions for Investors

• Do not add outright KO at current valuation; place a buy alert at a 3% forward dividend yield or approximately a return to the low-20x forward-P/E range, contingent on organic revenue growth remaining positive.
• For a 1-3 month tactical hedge, initiate a modest short KO / long XLP pair only if KO breaks below its post-earnings support level; target 8-12% relative downside, with a 5% relative stop if revised guidance or unit-case growth accelerates.
• For defined-risk downside exposure around the next earnings print, consider KO put spreads 5-10% below spot with 2-4 months to expiry; this expresses valuation-normalization risk while avoiding open-ended short exposure and dividend carry.
• Monitor quarterly organic sales growth, unit-case volume excluding major-event markets, and the USD index. Exit bearish positioning if management sustains double-digit EPS growth without material FX benefit, or if forward EPS estimates rise enough to reduce the forward multiple below 22x without price weakness.
• Avoid using PEP as a standalone long merely on relative valuation; require evidence of North American snack-volume stabilization and margin recovery before treating the KO/PEP spread as a convergence trade.